[1] Soengas MS,Lowe SW.Apoptosis and melanoma chemoresistance.Oncogene,2003,22(20):3138-3151. [2] Aggarwal BB,Shishodia S.Molecular targets of dietary agents for prevention and therapy of cancer.Biochem Pharmacol,2006,71 (10):1397-1421. [3] 牟霞,陆洪光,吴承龙,等.B16小鼠皮肤恶性黑素瘤模型的建立.中华皮肤科杂志,2004,37(10):613. [4] Wang LY,Taverna FA,Huang XP,et al.Phosphorylation and modulation of a kainate receptor (GluR6) by cAMP-dependent protein kinase.Science,1993,259(5098):1173-1175. [5] Karin M.Nuclear factor-kappaB in cancer development and progression.Nature,2006,441 (7092):431-436. [6] Aggarwal BB,Shishodia S,Takada Y,et al.Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.Clin Cancer Res,2005,11 (20):7490-7498. [7] LoTempio MM,Veena MS,Steele HL,et al.Curcumin suppresses growth of heed and neck squamous cell carcinoma.Clin Cancer Res,2005,11 (19 Pt 1):6994-7002. [8] McNulty SE,Tohidian NB,Meyskens FL Jr.RelA,p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B.Pigment Cell Res,2001,14(6):456-465. [9] Li H,Niederkorn JY,Neelam S,et al.Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.Exp Eye Res,2006,83(1):176-182. [10] Zaffaroni N,Pennati M,Daidone MG.Survivin as a target for new anticancer interventions.J Cell Mol Med,2005,9 (2):360-372. [11] Congmin G,Mu Z,Yihui M,et al.Survivin——an attractive target for RNAi in non-Hodgkin's lymphoma,Daudi cell line as a model.Leuk Lymphoma,2006,47(9):1941-1948. [12] Du ZX,Zhang HY,Gao da X,et al.Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells.Exp Mol Med,2006,38(3):230-240. |